Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization
- PMID: 35695714
- DOI: 10.1080/08982104.2022.2085742
Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization
Abstract
Transdermal drug delivery systems (TDDSs) have gained substantial attention during the last decade. TDDS are versatile delivery systems in which active components are delivered to skin for local effects or systemic delivery of active pharmaceutical through the skin. Overcoming stratum corneum is the most challenging step of delivering drugs through the skin. Lipid-based vesicular delivery systems due to the capability of the delivery of both hydrophilic and hydrophobic drugs are becoming more popular during the recent years. Ethosomes are innovative, biocompatible, biodegradable and non-toxic form of lipid-based vesicles that efficiently enable to entrap drugs of various physicochemical properties. These are other forms of liposome which contain high amounts of ethanol in their structure that enabling ethosomes to efficiently penetrate through deeper layers of skin. Ethosomes have various compositions based on their type but are mainly composed of phospholipids, ethanol, water and the active components. Ethosomes are easily manufactured and they are superior compared to liposomes in terms of different aspects due to the presence of ethanol. The purpose of this review is to thoroughly focus on various aspects of ethosomes, including mechanism of penetration, advantages and disadvantages, characterisation and applications.
Keywords: Ethosome; dermal drug delivery systems; skin permeation; transdermal drug delivery systems; vesicular nanocarriers.
Similar articles
-
Ethosomes as a carrier for transdermal drug delivery system: methodology and recent developments.J Liposome Res. 2024 Dec;34(4):697-714. doi: 10.1080/08982104.2024.2339896. Epub 2024 Apr 27. J Liposome Res. 2024. PMID: 38676416 Review.
-
Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.Eur J Pharm Biopharm. 2018 Jun;127:387-397. doi: 10.1016/j.ejpb.2018.03.008. Epub 2018 Mar 23. Eur J Pharm Biopharm. 2018. PMID: 29581043
-
Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.Molecules. 2020 Jun 27;25(13):2959. doi: 10.3390/molecules25132959. Molecules. 2020. PMID: 32605117 Free PMC article. Review.
-
Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.Int J Nanomedicine. 2017 Apr 26;12:3357-3364. doi: 10.2147/IJN.S134708. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28490875 Free PMC article.
-
Transdermal applications of ethosomes - a detailed review.J Liposome Res. 2019 Jun;29(2):103-113. doi: 10.1080/08982104.2018.1517160. Epub 2018 Oct 12. J Liposome Res. 2019. PMID: 30156120 Review.
Cited by
-
Designed Fabrication of Phloretin-Loaded Propylene Glycol Binary Ethosomes: Stability, Skin Permeability and Antioxidant Activity.Molecules. 2023 Dec 21;29(1):66. doi: 10.3390/molecules29010066. Molecules. 2023. PMID: 38202649 Free PMC article.
-
High-Performance Liquid Chromatography (HPLC) Method Validation for Identifying and Quantifying Rebamipide in Ethosomes.Cureus. 2024 Mar 12;16(3):e56061. doi: 10.7759/cureus.56061. eCollection 2024 Mar. Cureus. 2024. PMID: 38618434 Free PMC article.
-
Recent Advances in Nanotechnology-Mediated Noninvasive Transdermal and Topical Delivery of Proteins.Small Sci. 2024 Jul 16;4(10):2400175. doi: 10.1002/smsc.202400175. eCollection 2024 Oct. Small Sci. 2024. PMID: 40212262 Free PMC article.
-
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage.Life (Basel). 2024 Jan 21;14(1):155. doi: 10.3390/life14010155. Life (Basel). 2024. PMID: 38276284 Free PMC article.
-
Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.ACS Pharmacol Transl Sci. 2025 Jan 23;8(2):308-338. doi: 10.1021/acsptsci.4c00679. eCollection 2025 Feb 14. ACS Pharmacol Transl Sci. 2025. PMID: 39974652 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources